Flexus Biosciences was a South San Francisco / San Carlos, California biotechnology company founded in 2013 to develop small-molecule cancer immunotherapies, most notably inhibitors of the IDO/TDO immunosuppressive pathway (lead IDO1 program F001287). - View it on GitHub